Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Samuel Zachary Goldhaber, M.D.

Co-Author

This page shows the publications co-authored by Samuel Goldhaber and Joseph Loscalzo.
Connection Strength

0.461
  1. Urokinase versus tissue plasminogen activator in pulmonary embolism. Lancet. 1988 Oct 15; 2(8616):915.
    View in: PubMed
    Score: 0.101
  2. Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J. 1988 Aug; 116(2 Pt 1):505-8.
    View in: PubMed
    Score: 0.099
  3. Thrombolytic therapy of acute pulmonary embolism: current status and future potential. J Am Coll Cardiol. 1987 Nov; 10(5 Suppl B):96B-104B.
    View in: PubMed
    Score: 0.094
  4. Tissue plasminogen activator and acute pulmonary embolism. J Cell Biochem. 1988 Dec; 38(4):303-12.
    View in: PubMed
    Score: 0.051
  5. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet. 1988 Aug 06; 2(8606):293-8.
    View in: PubMed
    Score: 0.050
  6. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. Circulation. 1987 Jun; 75(6):1200-3.
    View in: PubMed
    Score: 0.023
  7. Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator. Semin Thromb Hemost. 1987 Apr; 13(2):171-7.
    View in: PubMed
    Score: 0.023
  8. Acute pulmonary embolism treated with tissue plasminogen activator. Lancet. 1986 Oct 18; 2(8512):886-9.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.